Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
The American Journal of Case Reports|June 23, 2021
Multiple Gastric Carcinomas Associated with Epstein-Barr Virus and Helicobacter pylori: A Thought-Provoking CaseTomohide Hori, Hidekazu Yamamoto, Hideki Harada, et al.Surgery|August 14, 2022
Impact of anatomical liver resection on patient survival in KRAS-wild-type colorectal liver metastasis: A multicenter retrospective studyTakayuki Kawai, Takamichi Ishii, Yoichiro Uchida, et al.Surgery|November 16, 2019
ALPlat criterion for the resection of hepatocellular carcinoma based on a predictive model of posthepatectomy liver failureGen Yamamoto, Kojiro Taura, Iwao Ikai, et al.World Journal of Clinical Cases|September 28, 2019
Impact of continuous local lavage on pancreatic juice-related postoperative complications: Three case reportsTomohide Hori, Kohei Ogawa, Hidekazu Yamamoto, et al.Annals of Surgical Oncology|July 8, 2017
A Multicenter Phase 2 Study on the Feasibility and Efficacy of Neoadjuvant Chemotherapy Without Radiotherapy for Locally Advanced Rectal CancerSuguru Hasegawa, Saori Goto, Takuya Matsumoto, et al.Journal of Hepato-Biliary-Pancreatic Sciences|August 27, 2014
Indication for neoadjuvant chemotherapy in patients with colorectal liver metastases based on a nomogram that predicts disease-free survivalMasayuki Okuno, Etsuro Hatano, Satoru Seo, et al.Journal of Hepato-Biliary-Pancreatic Sciences|May 1, 2015
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-ras status for unresectable colorectal liver metastasis (BECK study)Etsuro Hatano, Masayuki Okuno, Kojiro Nakamura, et al.International Journal of Clinical Oncology|October 19, 2016
Multi-institutional phase II study on the feasibility of liver resection following preoperative mFOLFOX6 therapy for resectable liver metastases from colorectal cancersSatoshi Nagayama, Suguru Hasegawa, Koya Hida, et al.Journal of Hepato-Biliary-Pancreatic Sciences|May 4, 2020
Conversion to complete resection with mFOLFOX6 with bevacizumab or cetuximab based on K-RAS status for unresectable colorectal liver metastasis (BECK study): Long-term results of survivalMasayuki Okuno, Etsuro Hatano, Rei Toda, et al.Pageof 4